Peter Lavin
Impact in
- Nephrology top 0.5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Transplantation top 5%
Papers in
- Nephrology 20
- Renal Diseases and Glomerulopathies 18
- Chronic Kidney Disease and Diabetes 7
-
- Pharmaceutical Practices and Patient Outcomes 3
- Co-authors
- Michelle P. Winn (12 shared papers)Rasheed Gbadegesin (9 shared papers)Peter J. Conlon (13 shared papers)Andréy S. Shaw (2 shared papers)Haiyang Yu (1 shared paper)Martin R. Pollak (1 shared paper)Shreeram Akilesh (1 shared paper)Jeffrey B. Kopp (1 shared paper)
- Journals
- Journal of the American Society of Nephrology (8 papers)Kidney International (3 papers)Clinical Transplantation (2 papers)QJM (2 papers)Pediatric Nephrology (2 papers)
- Partner nations
- IrelandUnited StatesUnited Kingdom
In The Last Decade
Peter Lavin
42 papers receiving 2.4k citations
Peter Lavin's Hit Papers
Peers
Comparison fields: 5 of 94
- Nephrology 1.3k
- Transplantation 99
- Immunology 544
- Genetics 187
- Hematology 167
Countries citing papers authored by Peter Lavin
This map shows the geographic impact of Peter Lavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lavin more than expected).
Fields of papers citing papers by Peter Lavin
This network shows the impact of papers produced by Peter Lavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lavin. The network helps show where Peter Lavin may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Lavin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 519 |
| 2 | C3 glomerulopathy: consensus report Hit paper breakdown → | 2013 | 494 |
| 3 | 2011 | 228 | |
| 4 | 2019 | 208 | |
| 5 | 2014 | 120 | |
| 6 | 2011 | 117 | |
| 7 | 2012 | 112 | |
| 8 | 2010 | 71 | |
| 9 | 2011 | 63 | |
| 10 | 2013 | 61 | |
| 11 | 2015 | 48 | |
| 12 | 2014 | 46 | |
| 13 | 2018 | 41 | |
| 14 | 2011 | 31 | |
| 15 | 2014 | 31 | |
| 16 | 2008 | 25 | |
| 17 | 2009 | 25 | |
| 18 | 2019 | 24 | |
| 19 | 2017 | 19 | |
| 20 | 2019 | 19 |
About Peter Lavin
Peter Lavin is a scholar working on Nephrology, Geriatrics and Gerontology, Genetics, Genetics and Transplantation, having authored 44 papers that have together received 2.4k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (18 papers), Chronic Kidney Disease and Diabetes (7 papers), Genetic and Kidney Cyst Diseases (4 papers), Renal and related cancers (4 papers), Complement system in diseases (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Tuberous Sclerosis Complex Research (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Nephrology (1.3k citations), Transplantation (99 citations), Immunology (544 citations), Genetics (187 citations) and Hematology (167 citations). Peter Lavin has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Michelle P. Winn, Rasheed Gbadegesin, Peter J. Conlon, Andréy S. Shaw, Haiyang Yu, Martin R. Pollak, Shreeram Akilesh, Jeffrey B. Kopp, Corinne Antignac and Hani Y. Suleiman. Their work appears in journals such as Journal of the American Society of Nephrology, Kidney International, Clinical Transplantation, QJM and Pediatric Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.